Freestone Capital Holdings’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-439
Closed -$208K 664
2026
Q1
$208K Buy
+439
New +$221K 0.01% 513
2022
Q2
Sell
-1,455
Closed -$365K 495
2022
Q1
$365K Buy
1,455
+204
+16% +$51.2K 0.01% 428
2021
Q4
$321K Buy
1,251
+371
+42% +$90.8K 0.01% 389
2021
Q3
$214K Buy
+880
New +$215K 0.01% 392
2021
Q1
Sell
-435
Closed -$71.5K 685
2020
Q4
$71.5K Buy
435
+139
+47% +$20.3K ﹤0.01% 494
2020
Q3
$36.9K Buy
+296
New +$36.6K ﹤0.01% 536

Other funds holding HCA

Freestone Capital Holdings's HCA Position: Q2 2026 in Review

Freestone Capital Holdings sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 439 shares — an estimated $208K sold.

Freestone Capital Holdings first reported a position in HCA in Q3 2020 and held it in 6 quarters. The position peaked at $365K in Q1 2022. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Freestone Capital Holdings reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Freestone Capital Holdings sold 439 HCA Healthcare shares in Q2 2026, an estimated $208K.
  • Freestone Capital Holdings first reported a position in HCA Healthcare in Q3 2020 and held it in 6 quarters.
  • Freestone Capital Holdings's HCA Healthcare position peaked at $365K in Q1 2022.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.